What's Happening

Indicated for the treatment of Alzheimer's disease. Treatment with Kisunla should be initiated in patient with mild cognitive impairment or mild dementia stage of disease, the population in which the treatment was initiated in the clinical trials

A biosimilar to Stelara; indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn’s disease, and moderately to severely active ulcerative colitis

A new chewable tablet indicated for the treatment of erectile dysfunction, and the signs and symptoms of benign prostatic hyperplasia

Indicated for the treatment of HIV-1 infection, in combination with other antiretroviral agents

Indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure

Indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression

A biosimilar of Stelara^®, this drug is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis

A long-acting, atypical antipsychotic indicated for the treatment of schizophrenia

A first-in-class biologic indicated for the treatment of pulmonary arterial hypertension to increase exercise capacity and reduce the risk of clinical worsening events

Indicated for the treatment of pulmonary arterial hypertension, both in patients who are treatment naïve or who are already on an ERA, PDE5 inhibitor or both